Barclays Maintains Overweight on Keurig Dr Pepper, Lowers Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper (NASDAQ:KDP) but lowers the price target from $38 to $37.
July 19, 2024 | 4:49 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper but lowers the price target from $38 to $37.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100